ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.

MLA

Savir-Baruch, Bital, et al. “ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.” Clinical Nuclear Medicine, vol. 43, no. 12, Dec. 2018, pp. 909–17. EBSCOhost, https://doi.org/10.1097/RLU.0000000000002310.

APA

Savir-Baruch, B., Banks, K. P., McConathy, J. E., Molchanova-Cook, O. P., Parent, E. E., Takalkar, A., Tulchinsky, M., Yu, J. Q., Subramaniam, R. M., & Schuster, D. M. (2018). ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer. Clinical Nuclear Medicine, 43(12), 909–917. https://doi.org/10.1097/RLU.0000000000002310

Chicago

Savir-Baruch, Bital, Kevin P Banks, Jonathan E McConathy, Olga P Molchanova-Cook, Ephraim E Parent, Amol Takalkar, Mark Tulchinsky, Jian Q Yu, Rathan M Subramaniam, and David M Schuster. 2018. “ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.” Clinical Nuclear Medicine 43 (12): 909–17. doi:10.1097/RLU.0000000000002310.